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Summary Administration of 5-aminolaevulinic acid (ALA) leads to porphyrin accumulation in malignant and premalignant tissues, and ALA is
used as a prodrug in photodynamic therapy (PDT). To understand the mechanism of porphyrin accumulation after the administration of ALA
and to investigate whether ALA-induced protoporphyrin IX might be a suitable photosensitizer in Barrett's oesophagus and adenocarcinoma.
we determined the activities of porphobilinogen deaminase (PBG-D) and ferrochelatase (FC) in various malignant and premalignant as well
as in normal tissues of the human oesophagus. A PDT power index for ALA-induced porphyrin accumulation, the ratio of PBG-D to FC
normalized for the normal squamous epithelium of the oesophagus, was calculated to evaluate intertissue variation in the ability to
accumulate porphyrins. In malignant and premalignant tissue a twofold increased PBG-D activity and a marginally increased FC activity was
seen compared with normal squamous epithelium. A significantly increased PDT power index in Barrett's epithelium and adenocarcinoma
was found. Our results suggest that, after the administration of ALA, porphyrins will accumulate in a greater amount in Barrett's epithelium
and adenocarcinoma of the oesophagus because of an imbalance between PBG-D and FC activities. The PDT power index here defined
might be a useful indicative parameter for predicting the susceptibility of these tissues to ALA-PDT.
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Haem biosxnthesis (FFigure 1) is essential to every cell and requires
eiaht molecules of gl-cine and eight molecules of succinvI CoA
for each molecule of haem. The first intermediate is 5-amino-
laevulinic acid (ALA): two molecules of ALA are converted to
porphobilinogen. which is metabolized to porphyrinogen interme-
diates by porphobilinogen deaminase (PBG-D). The last step is the
incorporation of iron into protoporphxrin IX (PPIX). catalysed by
ferrochelatase (FC. The synthesis of ALA is the rate-limiting
step. If exogenous ALA is provided. then other enzymes become
rate-limitincy in haem formation.
Some cancer cells have been found to have an increased PBG-D
activit-y of (Rubino and Rasetti. 1966: Schoenfeld et al. 1988a:
Navone et al. 1990. 1991: el-Sharabasx et al. 1992). and in most
studies these cells have been found to have a decreased FC activitv
(Rubino and Rasetti. 1966: Dailex and Smith. 1984: Smith. 1987:
el-Sharabasv et al. 1992: Van Hillegersberg et al. 1992). For such
cells. administration of ALA will lead to the accumulation of
porphyrins. especially PPIX (Anderson et al. 1981). This provides
a biological rationale for the clinical use of ALA photodynamic
therapy (ALA-PDT).
Barrett's (columnar-lined) oesophagus results from long-term
gastro-oesophageal reflux (Mossberg. 1966). It is ofclinical impor-
tance because of its malignant potential. Barrett's oesophagus can
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lead to the development of adenocarcinoma through a multistep
process of progression from metaplasia to lo%--agrade dysplasia.
high-grade dysplasia and ultimately to invasixe cancer (Hamilton
and Smith. 1987: Hameeteman et al. 1989). High-grade dysplasia
in Barrett's oesophagus presents a difficult management problem.
Options include endoscopic sun eillance and/or oesophagectomr
(Lexine et al. 1993: Clark et al. 1996: Cameron. 1997). A new non-
surgical management option involhes eradicating the dysplastic
epithelium and columnar mucosa by PDT. In contrast to other
photosensitizers. mans ofwhich localize in the microxvasculature of
all tissue layers ofhollow organs. ALA induces much higher levels
of PPIX in the mucosa than submucosa or muscularis mucosae
(Loh et al. 1993). ALA-PDT has been used to treat high-grade
dysplasia in Barrett's oesophagus. resulting in necrosis of
dysplastic mucosa with regeneration of normal squamous mucosa
(Gossner et al. 1995: Reaula et al. 1995: Barr et al. 1996).
To optimize ALA-PDT for Barrett's oesophagus and early
carcinoma. knowledae of the mechanism of porphyrin accumula-
tion in these tissues is required. We determined the activities of
PBG-D and FC in normal tissue as well as in malignant and
premalignant tissue ofthe human oesophagrus. These two enzymes
play an important role after the administration of ALA: PBG-D is
in many cells the rate-limiting enzyme w-hen exogenous ALA is
administered and FC is the enzN-me directly responsible for the
conx ersion of PPIX to haem. We propose the use of a PDT power
index for the intertissue variation in the abilitv to accumulate
PPIX. in order to create a parameter that might indicate the suscep-
tibilitv oftissues to ALA-PDT.
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MATERIALS AND METHODS
Tissue samples
Between August 1996 and February 1997 tissue was obtained
from 27 patients (16 men and 11 women) undergoing an
oesophageal resection. The mean age was 61 years (43-81 years).
Nine patients had a squamous cell carcinoma. 18 had an adenocar-
cinoma of the distal oesophagus and in nine of these patients
Barrett's epithelium was present. Samples from histologically
proven Barrett's mucosa, squamous cell carcinoma and adenocar-
cinoma as well as samples from normal gastric mucosa and normal
squamous epithelium were taken immediately after the resection.
In some instances, samples could not be taken from Barrett's
mucosa. Tissue samples were embedded in formalin. sectioned
and stained with haematoxylin and eosin. The grade of tumour
differentiation was described as well as the grade of dysplasia in
Barrett's mucosa. Barrett's mucosa was classified as indefinite.
low-grade dysplasia (LGD) and high-grade dysplasia (HGD). In
addition, adjacent tissue samples were frozen (-70'C) until the
moment of biochemical analysis. All determinations were
performed in duplicate within 6 weeks ofresection. Control exper-
iments showed no change in activities in samples stored at -70'C
for this time. This temperature was found to be essential: when
stored at -200C, FC activity decreased within a few days. whereas
the PBG-D activity remained stable for weeks.
Chemicals
The following reagents were obtained from Porphyrin Products
(Logan. UT. USA): PPIX disodium salt. zinc PPIX and porpho-
bilinogen (PBG). Coproporphyrin and Triton X-100 were
purchased from Sigma Chemical (St Louis, MO. USA). Tris-HCl
was purchased from Boehringer Mannheim (Mannheim.
Germany) and other chemicals were purchased from Merck
(Darmstadt. Germany).
Table 1 Enzyme actvites and PDT power indexes
PBG- Re
Squamous epitheium n = 27 22.8 ± 7.3 (10-42)
Gastric mucosa n = 27 24.9 ± 8.6 (10-42)
Barrett's epithelium n = 7 40.6 ± 13.7' (21-63)
Adenocarcinoma n= 17 55.0± 19.9* (25-93)
Squamous cell carcinoma n = 9 37.6 ± 14.1t (21-67)
Ferrohelatase
Squamous epitelium n = 24 391 ± 152 (124-718)
Gastric mucosa n= 24 685 ±265W (336-1187)
Barrett's epitelium n =6 437±203t (176-726)
Adenocarcinoma n= 16 582 ± 220Y (230-1048)
Squamous cell carcinoma n =7 558 ± 332 (251-1263)
PDTpowerindex
Squamous epithelium n = 24 1.0
Gastric mucosa n = 24 0.7± 0.2* (0.3-1.1)
Barrett's epithelium n = 6 1.8 ± 0.8' (0.8-3.0)
Adenocarcinorra n= 16 1.9 ± 1.2' (0.6-5.6)
Squamous cell carcinoma n = 7 1.1 ± 0.5 (0.6-2.0)
Vmol mg proteirr1 hI, mean ± s.d. (tP < 0.05, *P < 0.01).
FC and PBG-D assays
FC activity was measured by a modification ofthe method ofLi et
al (1987) as described previously (Van Hillegersberg et al. 1992).
PBG-D measurements were perfonned by a modification of the
method of Wilson et al (1986). Tissue samples. kept on ice. were
homogenized in water (1:5 wt:wt) using a PotterElvehjem homog-
enizer (Kontess Glass. Vineland. NJ. USA). An aliquot of50pL of
a 200 M solution of PBG in 0.1 M Tris-HCL buffer. pH 8.0. was
added to 50 1 ofthe homogenate. This mixture was incubated for
1 h at 370C. The reaction was stopped by adding 600 p1 of Tris-
HC1 buffer (Tris-HCI 50 r-m. trichloroacetic acid 1.5 M in aqua
dest.) (5:7. v:v). After 5 min exposure to UV light (350 nm). to
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convert porphyrinogens toporphyrins. the samples werecentrifuged
for 10 min at 14 000 g (Eppendorf centrifuge, Merck Nederland.
The Netherlands), and the fluorescence of the supernatant was
measured at 408 nm excitation and 648 nm emission wavelength
(Perkin Elmer LS SB with a red sensitive photomultplier). Values
were calculated according to a standard curve ofcoproporphyrin 1m
in Tris-HCI buffer (1:1. v:v). Results were expressed as pmol of
porphyrins formed per mgprotein per hour. Protein was determined
according to the method ofLowry et al (1951).
The PDT power index
The ratio of PBG-D to FC, introduced as the PDT power index.
was calculated, with the enzyme activities in each tissue sample
relative to the activities in normal squamous epithelium per
individual. This index was calculatedaccording to the formula:
[PBG-D(tissue)/FC(tissue)] x
[FC(squamousepithelium)IPBG-D (squamous epithelium)]
Statistical analysis
Data are expressed as means ± s.d. and were analysed for statis-
tical significance using the Wilcoxon matched-pairs signed rank-
sum test. The enzyme activities ofthe malignant andpremalignant
tissues werecompared with the adjacent normal tissue in the same
patient.
RESULTS
All results are shown in Table 1. A twofold increase in PBG-D
activity was found in Barrett's epithelium (P =0.018) and in
adenocarcinoma of the oesophagus (P =0.001) compared with
normal squamous epithelium. Regarding the activity of FC.
although the mean values were significantly increased compared
with normal squamous epithelium, this increase was less marked
compared with the PBG-D activity increase. This resulted in a
significant increase in the PDT power index in Barrett's oesoph-
agus (P = 0.046) and adenocarcinoma (P =0.003) compared with
the normal squamous epithelium. Of the five cases of Barrett's
oesophagus in which the index was calculated and the grade of
dysplasia determined, four cases were classified as LGD and one
case as HGD. The PDT power indexes were 0.8. 1.4. 1.4. 1.6 for
LGD and 2.4 for HGD.
DISCUSSION
Several groups have shown that porphyrins accumulate in
neoplastic tissue after the administration ofALA (Peng et al, 1997.
review). Normally, haemsynthesis is regulated by substrate avail-
ability and by feedback inhibition of the enzyme ALA synthase.
The concentration of substrates and intermediates are usually far
below the Michaelis constants of the enzymes, in which case
intermediates are metabolized to haem (Bottomly and Muller-
Eberhard, 1988). When exogenous ALA is administered. normal
cells willrapidlyproduce haem. An excess ofexogenous ALA will
initially overload the system and porphyrin intermediates will
accumulate. The presence of the intermediates contributes to
photosensitivity ofnormal cells, but these intermediates arerapidly
metabolized into haem. Inmalignant andpremalignant tissue ofthe
oesophagus. we found increased PBG-D and FC activities
compared with normal squamous epithelium. and an imbalance
between these activities. These results are in line with those found
in our previous smaller studies (Hinnen et al, 1997a, b). Owing to
individual patient and tissue variations in the activities of PBG-D
and FC, alsodescribedby others (Rubino and Rasetti. 1966: Dailey
and Smith, 1984; Schoenfeld et al, 1987, 1988ab: Smith, 1987;
Navone et al. 1990; el-Sharabasy et al. 1992; Van Hillegersberg et
al. 1992), the activity of these two haem enzymes can be better
described relative to each other. This ratio. which we propose to
call the PDT power index, reflects the enzymatic ability ofcells to
accumulate porphyrins afterALA administration and mightpredict
the susceptibility of tissue to ALA-PDT. The PDT power index
was significantly increased in Barrett's epithelium and adenocarci-
noma compared with normal squamous epithelium. indicating that
the FC activity was relatively low compared with the PBG-D
activity. As this index can also be derived from biopsy specimens,
e.g. oesophagus orBarrett, it could be applied before ALA-PDT to
estimate tissue susceptibility.
Increased PBG-D activity relative to normal tissue has consis-
tently been found in tumours (Schoenfeld et al. 1988a: Navone et
al, 1990, 1991; el-Sharabasy et al. 1992) as well as in rapidly
dividing cells. e.g. regenerating liver cells (Schoenfeld et al, 1987.
1988b),suggesting that this phenomenon might be common in situ-
ations of increased cell replication. In contrast to the consistent
studies concerning the activity of PBG-D. there seems to be a
difference in FC activity among different tumourtypes (Rubino and
Rasetti. 1966; Dailey and Smith, 1984: Smith. 1987; el-Sharabasy
et al, 1992; Van Hillegersberg et al, 1992). Dailey and Smith (1984)
found a decreased FC activity in the Morris hepatoma model;
however, they also pointed out that some porphyrins can act as
inhibitors of FC. Smith (1987) found decreased FC activities in
human skin tumours but also in normal skin tissue compared with
those in rat liver mitochondria. El-Sharabasy et al (1992) deter-
mined the FC activity in whole-blood samples of children and
adults with acute lymphoblastic leukaemia (ALL). non-Hodgkin's
lymphoma (NHL) or Hodgkin's disease (HD) and found lowered
activities in patients with ALL, slightly decreased activities and
increased activities of FC in blood of patients with NHL and HD
respectivelycompared with healthy control groups. Compared with
liver, which is one of the main haem-synthesizing tissues. most
tissues have low enzyme activities (Webberet al. 1997). Our group
found the FC activity to be decreased in a colon carcinoma liver
metastasis model and we suggested applying ALA-PDT to patients
with these liver metastases (Van Hillegersberg et al, 1992).
Regarding the effect of the storage temperature on FC activity.
interpretation ofdata from other studies might be biased because of
differences in tissue storage.
In the gastrointestinal tract, accumulation of porphyrins after
ALA administration is more pronounced in the mucosa than in the
underlying submucosa and muscle layers. making ALA suitable for
treating most mucosal lesions (Bedwell et al. 1992: Loh et al. 1993:
Webber et al. 1997). In patients with familial adenomatous poly-
posis, no differences in PPIX concentrations were found between
normal and adenomatous tissue (Mlkvy et al, 1995). In the DMH
rat colonic tumour model the same group showed differences in the
levels ofPPIX between normal mucosa and tumour with a ratio of
1:6 (Bedwell et al. 1992). In another study they showed that higher
doses of ALA (60mg kg' instead of 30mg kg') improved the
tumour-normal mucosa PPIX sensitization ratio in patients with
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colon carcinoma (Regula et al. 1995). Webber et al (1997) showed
selective accumulation of PPIX in adenocarcinomas of the
gastrointestinal tract in 42 patients. Our biochemical study has
characterized the enzymatic capacities of haem biosynthesis in
normal. premalignant and malignant tissue of the human oesoph-
agus. These results provide evidence for the selectivity of PPIX
accumulation between normal and neoplastic tissue of the oesoph-
agus. Whether selective PPIX accumulation creates the possibility
of achieving selective necrosis is still in question. Recently. Bown
and Millson (1997) have stated that the selectivity of ALA-PDT-
induced necrosis. in the gastrointestinal tract. is between mucosa
and underlying submucosa and muscularis and not between normal
mucosa and neoplastic mucosa.
In conclusion. our study supports the use of ALA for selective
PDT in Barrett's oesophagus and early carcinoma. Information
about the PDT power index could be useful in predicting the effect
of ALA administration on porphyrin accumulation and therefore
on the susceptibility of the disorder to ALA-PDT.
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